484 related articles for article (PubMed ID: 15769469)
1. Domain interactions in the Fab fragment: a comparative evaluation of the single-chain Fv and Fab format engineered with variable domains of different stability.
Röthlisberger D; Honegger A; Plückthun A
J Mol Biol; 2005 Apr; 347(4):773-89. PubMed ID: 15769469
[TBL] [Abstract][Full Text] [Related]
2. Mutual stabilization of VL and VH in single-chain antibody fragments, investigated with mutants engineered for stability.
Wörn A; Plückthun A
Biochemistry; 1998 Sep; 37(38):13120-7. PubMed ID: 9748318
[TBL] [Abstract][Full Text] [Related]
3. Contributions of a highly conserved VH/VL hydrogen bonding interaction to scFv folding stability and refolding efficiency.
Tan PH; Sandmaier BM; Stayton PS
Biophys J; 1998 Sep; 75(3):1473-82. PubMed ID: 9726949
[TBL] [Abstract][Full Text] [Related]
4. Engineering antibodies for stability and efficient folding.
Honegger A
Handb Exp Pharmacol; 2008; (181):47-68. PubMed ID: 18071941
[TBL] [Abstract][Full Text] [Related]
5. Structure-based stability engineering of the mouse IgG1 Fab fragment by modifying constant domains.
Teerinen T; Valjakka J; Rouvinen J; Takkinen K
J Mol Biol; 2006 Aug; 361(4):687-97. PubMed ID: 16876195
[TBL] [Abstract][Full Text] [Related]
6. Noncovalent association of heavy and light chains of human immunoglobulins. IV. The roles of the CH1 and CL domains in idiotypic expression.
Rinfret A; Horne C; Dorrington KJ; Klein M
J Immunol; 1985 Oct; 135(4):2574-81. PubMed ID: 3928754
[TBL] [Abstract][Full Text] [Related]
7. Functional mapping of conserved residues located at the VL and VH domain interface of a Fab.
Chatellier J; Van Regenmortel MH; Vernet T; Altschuh D
J Mol Biol; 1996 Nov; 264(1):1-6. PubMed ID: 8950262
[TBL] [Abstract][Full Text] [Related]
8. Association of antibody chains at different stages of folding: prolyl isomerization occurs after formation of quaternary structure.
Lilie H; Rudolph R; Buchner J
J Mol Biol; 1995 Apr; 248(1):190-201. PubMed ID: 7731044
[TBL] [Abstract][Full Text] [Related]
9. Different equilibrium stability behavior of ScFv fragments: identification, classification, and improvement by protein engineering.
Wörn A; Plückthun A
Biochemistry; 1999 Jul; 38(27):8739-50. PubMed ID: 10393549
[TBL] [Abstract][Full Text] [Related]
10. DNA binding by the VH domain of anti-Z-DNA antibody and its modulation by association of the VL domain.
Chen Y; Stollar BD
J Immunol; 1999 Apr; 162(8):4663-70. PubMed ID: 10202006
[TBL] [Abstract][Full Text] [Related]
11. The scFv fragment of the antibody hu4D5-8: evidence for early premature domain interaction in refolding.
Jäger M; Gehrig P; Plückthun A
J Mol Biol; 2001 Feb; 305(5):1111-29. PubMed ID: 11162118
[TBL] [Abstract][Full Text] [Related]
12. The influence of the framework core residues on the biophysical properties of immunoglobulin heavy chain variable domains.
Honegger A; Malebranche AD; Röthlisberger D; Plückthun A
Protein Eng Des Sel; 2009 Mar; 22(3):121-34. PubMed ID: 19136675
[TBL] [Abstract][Full Text] [Related]
13. Bivalent Fv antibody fragments obtained by substituting the constant domains of a fab fragment with heterotetrameric molybdopterin synthase.
Petrov K; Dion M; Hoffmann L; Dintinger T; Defontaine A; Tellier C
J Mol Biol; 2004 Aug; 341(4):1039-48. PubMed ID: 15328616
[TBL] [Abstract][Full Text] [Related]
14. The importance of framework residues H6, H7 and H10 in antibody heavy chains: experimental evidence for a new structural subclassification of antibody V(H) domains.
Jung S; Spinelli S; Schimmele B; Honegger A; Pugliese L; Cambillau C; Plückthun A
J Mol Biol; 2001 Jun; 309(3):701-16. PubMed ID: 11397090
[TBL] [Abstract][Full Text] [Related]
15. A natural antibody missing a cysteine in VH: consequences for thermodynamic stability and folding.
Proba K; Honegger A; Plückthun A
J Mol Biol; 1997 Jan; 265(2):161-72. PubMed ID: 9020980
[TBL] [Abstract][Full Text] [Related]
16. Helix-stabilized Fv (hsFv) antibody fragments: substituting the constant domains of a Fab fragment for a heterodimeric coiled-coil domain.
Arndt KM; Müller KM; Plückthun A
J Mol Biol; 2001 Sep; 312(1):221-8. PubMed ID: 11545598
[TBL] [Abstract][Full Text] [Related]
17. Dissecting the alternatively folded state of the antibody Fab fragment.
Feige MJ; Simpson ER; Herold EM; Bepperling A; Heger K; Buchner J
J Mol Biol; 2010 Jun; 399(5):719-30. PubMed ID: 20434459
[TBL] [Abstract][Full Text] [Related]
18. Domain interactions in antibody Fv and scFv fragments: effects on unfolding kinetics and equilibria.
Jäger M; Plückthun A
FEBS Lett; 1999 Dec; 462(3):307-12. PubMed ID: 10622716
[TBL] [Abstract][Full Text] [Related]
19. The nature of antibody heavy chain residue H6 strongly influences the stability of a VH domain lacking the disulfide bridge.
Langedijk AC; Honegger A; Maat J; Planta RJ; van Schaik RC; Plückthun A
J Mol Biol; 1998; 283(1):95-110. PubMed ID: 9761676
[TBL] [Abstract][Full Text] [Related]
20. Antibody variable region binding by Staphylococcal protein A: thermodynamic analysis and location of the Fv binding site on E-domain.
Starovasnik MA; O'Connell MP; Fairbrother WJ; Kelley RF
Protein Sci; 1999 Jul; 8(7):1423-31. PubMed ID: 10422830
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
